Brief: RetinalGenix and RGEN Clinical Genotyping Lab Partner to Advance Early Disease Detection
01/10/2025 11:08
Oct 1 (Reuters) - RetinalGenix Technologies Inc RTGN.PK: RETINALGENIX TECHNOLOGIES AND RGEN CLINICAL GENOTYPING LABORATORY ANNOUNCE STRATEGIC COLLABORATION TO ADVANCE EARLY DETECTION OF NEURODEGENERATIVE, SYSTEMIC, AND RETINAL DISEASES Source text: ID:nGNX7pKB3t Further company coverage: RTGN.PK ((Reuters.Briefs@thomsonreuters.com;))